Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the...
Gespeichert in:
| Veröffentlicht in: | Journal of controlled release 2021-08, Vol.336, p.354-374 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 374 |
|---|---|
| container_issue | |
| container_start_page | 354 |
| container_title | Journal of controlled release |
| container_volume | 336 |
| creator | Hasanzadeh, Akbar Alamdaran, Masoomeh Ahmadi, Sepideh Nourizadeh, Helena Bagherzadeh, Mohammad Aref Mofazzal Jahromi, Mirza Ali Simon, Perikles Karimi, Mahdi Hamblin, Michael R. |
| description | The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SARS-CoV-2. Smart nanocarriers have accelerated the design of several therapeutic, prophylactic, or immune-mediated approaches against COVID-19. Some nanovaccines have even entered Phase IΙ/IIΙ clinical trials. Several rapid and cost-effective COVID-19 diagnostic techniques have also been devised based on nanobiosensors, lab-on-a-chip systems, or nanopore technology. Here, we provide an overview of the emerging role of nanotechnology in the prevention, diagnosis, and treatment of COVID-19.
[Display omitted] |
| doi_str_mv | 10.1016/j.jconrel.2021.06.036 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8226031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365921003345</els_id><sourcerecordid>2545995345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-da4cca92212160fdc82098c6878d1f7d282390a73164077b647ff5a985e943093</originalsourceid><addsrcrecordid>eNqFkVtvEzEQhS1ERdPCTwDtIw_s4vuFBxBKuUSqqJCAV8u1vYmjXTu1vZXKr-9GCRV96tNoNN-cGZ0DwGsEOwQRf7_ttjbF7IcOQ4w6yDtI-DOwQFKQlirFnoPFzMmWcKZOwVkpWwghI1S8AKeEIsEI5wvw84eJqXq7iWlI67vGrE2IpTbLqz-rixapD81qHKcY_poaUnzXuGDWMZUabGOia-rGZ7Pz074vdXLBl5fgpDdD8a-O9Rz8_vrl1_J7e3n1bbX8fNlaykVtnaHWGoUxwojD3lmJoZKWSyEd6oXDEhMFjSCIUyjENaei75lRknlFCVTkHHw86O6m69E762PNZtC7HEaT73QyQT-exLDR63SrJcYcEjQLvD0K5HQz-VL1GIr1w2CiT1PRmFE2-0gom1F2QG1OpWTfP5xBUO_j0Ft9jEPv49CQ6zmOee_N_z8-bP3zfwY-HQA_O3UbfNbFBh-tdyF7W7VL4YkT9_jenuU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2545995345</pqid></control><display><type>article</type><title>Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hasanzadeh, Akbar ; Alamdaran, Masoomeh ; Ahmadi, Sepideh ; Nourizadeh, Helena ; Bagherzadeh, Mohammad Aref ; Mofazzal Jahromi, Mirza Ali ; Simon, Perikles ; Karimi, Mahdi ; Hamblin, Michael R.</creator><creatorcontrib>Hasanzadeh, Akbar ; Alamdaran, Masoomeh ; Ahmadi, Sepideh ; Nourizadeh, Helena ; Bagherzadeh, Mohammad Aref ; Mofazzal Jahromi, Mirza Ali ; Simon, Perikles ; Karimi, Mahdi ; Hamblin, Michael R.</creatorcontrib><description>The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SARS-CoV-2. Smart nanocarriers have accelerated the design of several therapeutic, prophylactic, or immune-mediated approaches against COVID-19. Some nanovaccines have even entered Phase IΙ/IIΙ clinical trials. Several rapid and cost-effective COVID-19 diagnostic techniques have also been devised based on nanobiosensors, lab-on-a-chip systems, or nanopore technology. Here, we provide an overview of the emerging role of nanotechnology in the prevention, diagnosis, and treatment of COVID-19.
[Display omitted]</description><identifier>ISSN: 0168-3659</identifier><identifier>ISSN: 1873-4995</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2021.06.036</identifier><identifier>PMID: 34175366</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>COVID-19 ; Diagnosis ; Humans ; Immunization ; Nanotechnology ; Nanovaccine ; Pandemics ; Review ; SARS-CoV-2</subject><ispartof>Journal of controlled release, 2021-08, Vol.336, p.354-374</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><rights>2021 Elsevier B.V. All rights reserved. 2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-da4cca92212160fdc82098c6878d1f7d282390a73164077b647ff5a985e943093</citedby><cites>FETCH-LOGICAL-c467t-da4cca92212160fdc82098c6878d1f7d282390a73164077b647ff5a985e943093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jconrel.2021.06.036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34175366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasanzadeh, Akbar</creatorcontrib><creatorcontrib>Alamdaran, Masoomeh</creatorcontrib><creatorcontrib>Ahmadi, Sepideh</creatorcontrib><creatorcontrib>Nourizadeh, Helena</creatorcontrib><creatorcontrib>Bagherzadeh, Mohammad Aref</creatorcontrib><creatorcontrib>Mofazzal Jahromi, Mirza Ali</creatorcontrib><creatorcontrib>Simon, Perikles</creatorcontrib><creatorcontrib>Karimi, Mahdi</creatorcontrib><creatorcontrib>Hamblin, Michael R.</creatorcontrib><title>Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SARS-CoV-2. Smart nanocarriers have accelerated the design of several therapeutic, prophylactic, or immune-mediated approaches against COVID-19. Some nanovaccines have even entered Phase IΙ/IIΙ clinical trials. Several rapid and cost-effective COVID-19 diagnostic techniques have also been devised based on nanobiosensors, lab-on-a-chip systems, or nanopore technology. Here, we provide an overview of the emerging role of nanotechnology in the prevention, diagnosis, and treatment of COVID-19.
[Display omitted]</description><subject>COVID-19</subject><subject>Diagnosis</subject><subject>Humans</subject><subject>Immunization</subject><subject>Nanotechnology</subject><subject>Nanovaccine</subject><subject>Pandemics</subject><subject>Review</subject><subject>SARS-CoV-2</subject><issn>0168-3659</issn><issn>1873-4995</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVtvEzEQhS1ERdPCTwDtIw_s4vuFBxBKuUSqqJCAV8u1vYmjXTu1vZXKr-9GCRV96tNoNN-cGZ0DwGsEOwQRf7_ttjbF7IcOQ4w6yDtI-DOwQFKQlirFnoPFzMmWcKZOwVkpWwghI1S8AKeEIsEI5wvw84eJqXq7iWlI67vGrE2IpTbLqz-rixapD81qHKcY_poaUnzXuGDWMZUabGOia-rGZ7Pz074vdXLBl5fgpDdD8a-O9Rz8_vrl1_J7e3n1bbX8fNlaykVtnaHWGoUxwojD3lmJoZKWSyEd6oXDEhMFjSCIUyjENaei75lRknlFCVTkHHw86O6m69E762PNZtC7HEaT73QyQT-exLDR63SrJcYcEjQLvD0K5HQz-VL1GIr1w2CiT1PRmFE2-0gom1F2QG1OpWTfP5xBUO_j0Ft9jEPv49CQ6zmOee_N_z8-bP3zfwY-HQA_O3UbfNbFBh-tdyF7W7VL4YkT9_jenuU</recordid><startdate>20210810</startdate><enddate>20210810</enddate><creator>Hasanzadeh, Akbar</creator><creator>Alamdaran, Masoomeh</creator><creator>Ahmadi, Sepideh</creator><creator>Nourizadeh, Helena</creator><creator>Bagherzadeh, Mohammad Aref</creator><creator>Mofazzal Jahromi, Mirza Ali</creator><creator>Simon, Perikles</creator><creator>Karimi, Mahdi</creator><creator>Hamblin, Michael R.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210810</creationdate><title>Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies</title><author>Hasanzadeh, Akbar ; Alamdaran, Masoomeh ; Ahmadi, Sepideh ; Nourizadeh, Helena ; Bagherzadeh, Mohammad Aref ; Mofazzal Jahromi, Mirza Ali ; Simon, Perikles ; Karimi, Mahdi ; Hamblin, Michael R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-da4cca92212160fdc82098c6878d1f7d282390a73164077b647ff5a985e943093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>Diagnosis</topic><topic>Humans</topic><topic>Immunization</topic><topic>Nanotechnology</topic><topic>Nanovaccine</topic><topic>Pandemics</topic><topic>Review</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasanzadeh, Akbar</creatorcontrib><creatorcontrib>Alamdaran, Masoomeh</creatorcontrib><creatorcontrib>Ahmadi, Sepideh</creatorcontrib><creatorcontrib>Nourizadeh, Helena</creatorcontrib><creatorcontrib>Bagherzadeh, Mohammad Aref</creatorcontrib><creatorcontrib>Mofazzal Jahromi, Mirza Ali</creatorcontrib><creatorcontrib>Simon, Perikles</creatorcontrib><creatorcontrib>Karimi, Mahdi</creatorcontrib><creatorcontrib>Hamblin, Michael R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasanzadeh, Akbar</au><au>Alamdaran, Masoomeh</au><au>Ahmadi, Sepideh</au><au>Nourizadeh, Helena</au><au>Bagherzadeh, Mohammad Aref</au><au>Mofazzal Jahromi, Mirza Ali</au><au>Simon, Perikles</au><au>Karimi, Mahdi</au><au>Hamblin, Michael R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2021-08-10</date><risdate>2021</risdate><volume>336</volume><spage>354</spage><epage>374</epage><pages>354-374</pages><issn>0168-3659</issn><issn>1873-4995</issn><eissn>1873-4995</eissn><abstract>The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SARS-CoV-2. Smart nanocarriers have accelerated the design of several therapeutic, prophylactic, or immune-mediated approaches against COVID-19. Some nanovaccines have even entered Phase IΙ/IIΙ clinical trials. Several rapid and cost-effective COVID-19 diagnostic techniques have also been devised based on nanobiosensors, lab-on-a-chip systems, or nanopore technology. Here, we provide an overview of the emerging role of nanotechnology in the prevention, diagnosis, and treatment of COVID-19.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34175366</pmid><doi>10.1016/j.jconrel.2021.06.036</doi><tpages>21</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-3659 |
| ispartof | Journal of controlled release, 2021-08, Vol.336, p.354-374 |
| issn | 0168-3659 1873-4995 1873-4995 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8226031 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | COVID-19 Diagnosis Humans Immunization Nanotechnology Nanovaccine Pandemics Review SARS-CoV-2 |
| title | Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T05%3A54%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanotechnology%20against%20COVID-19:%20Immunization,%20diagnostic%20and%20therapeutic%20studies&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Hasanzadeh,%20Akbar&rft.date=2021-08-10&rft.volume=336&rft.spage=354&rft.epage=374&rft.pages=354-374&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2021.06.036&rft_dat=%3Cproquest_pubme%3E2545995345%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2545995345&rft_id=info:pmid/34175366&rft_els_id=S0168365921003345&rfr_iscdi=true |